Back

The underrepresentation of females in antihypertensive medication over the years: a scoping review

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Cardiovascular disease in women 1 Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Zenab Mohseni-Alsalhi

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Prognostic value of a left atrioventricular coupling index (LACI) in pre- and post-menopausal women. from the multi-ethnic study of atherosclerosis (MESA)
Doctor T. Pezel (Paris, FR)
Abstract Slides
Presentation thumbnail
Arterial health abnormalities in women with pre-eclampsia: contributing role of central obesity
Doctor A. Paquin (Ottawa, CA)
Abstract Slides
Presentation thumbnail
Sex differences in prevalence of electrocardiographic and echocardiographic left ventricular hypertrophy among patients with coronary artery disease
Doctor M. Eskuri (Oulu, FI)
Abstract Slides
Presentation thumbnail
Associations of comorbidity patterns and in-hospital outcomes in Chinese young females (< 55 years) presenting with st-segment elevation myocardial infarction: a nationwide registry study
Mr G. A (Tianjin, CN)
Abstract Slides
Presentation thumbnail
Characterizing left ventricular stiffness in women with signs and symptoms of ischemia with no obstructive coronary arteries
Mr A. Oneglia (Arlington, US)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular disease in women 1

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources